# Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）

> **NCT04027543** · — · COMPLETED · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 423 (actual)

## Conditions studied

- Radiotherapy Side Effect
- Chemotherapy Effect
- Oesophageal Carcinoma
- Effect of Drugs
- Safety Issues

## Interventions

- **COMBINATION_PRODUCT:** Neoadjuvant chemoradiotherapy
- **PROCEDURE:** Oesophagectomy
- **DRUG:** Neoadjuvant chemotherapy

## Key facts

- **NCT ID:** NCT04027543
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-14
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2020-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04027543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04027543, "Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04027543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*